The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Jul. 24, 2015
Applicant:

Basf SE, Ludwigshafen, DE;

Inventors:

Bernd Herzog, Grenzach-Wyhlen, DE;

Dieter Kockott, Hanau, DE;

Heike Flösser-Müller, Brasschaat, BE;

Assignee:

BASF SE, Ludwigshafen am Rhein, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 8/44 (2006.01); A61Q 17/04 (2006.01); A61K 8/49 (2006.01); A61K 8/35 (2006.01); A61K 8/29 (2006.01); A61K 8/37 (2006.01); A61K 8/41 (2006.01); A61K 8/40 (2006.01);
U.S. Cl.
CPC ...
A61K 8/445 (2013.01); A61K 8/29 (2013.01); A61K 8/35 (2013.01); A61K 8/37 (2013.01); A61K 8/40 (2013.01); A61K 8/415 (2013.01); A61K 8/496 (2013.01); A61K 8/4926 (2013.01); A61K 8/4946 (2013.01); A61K 8/4966 (2013.01); A61Q 17/04 (2013.01);
Abstract

The present invention relates to a sunscreen formulation comprising at least one of the UV filters (A) selected from (a) triazine derivatives; (b) cinnamic acid derivatives; (c) bis-resorcinyl triazines; (f) benzimidazole derivatives; (i) 4-Methylbenzylidene Camphor; (h) benzoyl piperazine derivatives; (j) benzoxazole derivatives; (k) diarylbutadiene derivatives; (I) phenyl benzotriazole derivatives; (n) benzylidene malonates; (o) TEA-Salicylate; (r) imidazoline derivatives; (u) inorganic UV filters selected from metal oxides; (v) naphthalates; and (w) merocyanine derivatives; and optionally comprising at least one of the UV filters (B) selected from (d) aminobenzophenone derivatives; (e) dibenzoylmethane derivatives; (g) β,β-Diphenylacrylate derivatives; (i) camphor derivatives different from; (o) salicylate derivatives different from; (p) anthranilate derivatives; and (s) benzalmalonate derivatives; wherein the ratio R of the effective irradiance for previtamin Dformation Eto the effective irradiance for erythema formation Eon the skin is at least 1.8, for increasing the transmittance of UV radiation on human skin for the production of cholecalciferol (previtamin D) and simultaneously for the use in a method for protecting the human skin against UV radiation when exposed to the sun, which method comprises applying said sunscreen formulation to the skin.


Find Patent Forward Citations

Loading…